Important matters:
Aurora-B (06681): Cognitive function assessment product for depressive patients obtained Class II medical device registration certificate from Beijing Drug Administration
Oukangvision Bio-B (01477): Fluoroclone intravitreal implant approved by the State Drug Administration for production in mainland China
Jiami Technology (08198) plans to cooperate with DC ARK in artificial intelligence computing capabilities and artificial intelligence data center business
Collumbotai Biotech (06990): The application for marketing of the core product TROP2 ADC lukansastuzumab (sAC-TMT) for new indications was accepted by the China Drug Administration
Lizhu Pharmaceutical (01513): Wantai soup granules obtained the “Drug Registration Certificate”
Hengrui Pharmaceutical (01276): Class 1 innovative drug, rimazolam toluene sulfonate for injection, was approved for new indications
Operating performance:
Lu Control (06623) announced third quarter results. Total revenue was 6.18 billion yuan, and new consumer finance loans increased 25.2% year over year
Huaneng International Power Co., Ltd. (00902) net profit of 7.822 billion yuan in the first three quarters decreased by 47.29% year-on-year
Huaqin Technology (03296) net profit of 4.323 billion yuan in the first three quarters increased 39.53% year-on-year
Guangdong Investment (00270)'s profit attributable to company owners in the first three quarters of HK$4.362 billion increased 7.3% year-on-year
Fosun Pharmaceutical (02196) released results for the first three quarters, net profit of 2,667 billion yuan, up 5.71% year-on-year
China Communications Construction (01800) signed new contracts of 1,171,296 billion yuan in the first three quarters, down 12.59% year-on-year
Hengrui Pharmaceutical (01276)'s net profit for the first three quarters was about 6.923 billion yuan, an increase of 20.38% over the previous year
Bubble Mart (09992)'s overall revenue for the third quarter fell 45%-50% year-on-year
Ferretti (09638)'s new order volume of 665 million euros in the first three quarters decreased by about 13.8% year-on-year
HSBC Holdings (00005) released results for the first three quarters, profit after tax of US$22.9 billion increased 28% year over year